(Q53298239)

13 May 2018

title

Feasibility of 90Y TOF PET-based dosimetry in liver metastasis therapy using SIR-Spheres. (English)

1 reference

13 May 2018

1 reference

Renaud Lhommel

1

1 reference

13 May 2018

Larry van Elmbt

2

1 reference

13 May 2018

Pierre Goffette

3

1 reference

13 May 2018

Marc Van den Eynde

4

1 reference

13 May 2018

François Jamar

5

1 reference

13 May 2018

Stanislas Pauwels

6

1 reference

13 May 2018

Stephan Walrand

7

1 reference

13 May 2018

publication date

27 April 2010

1 reference

13 May 2018

number of pages

9

1 reference

European Journal of Nuclear Medicine and Molecular Imaging

inferred from page(s)

published in

1 reference

13 May 2018

volume

37

1 reference

13 May 2018

issue

9

1 reference

13 May 2018

page(s)

1654-1662

1 reference

13 May 2018

The impact of PET and SPECT on dosimetry for targeted radionuclide therapy

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1470-9

Quantitation in PET using isotopes emitting prompt single gammas: application to yttrium-86.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1470-9

PET imaging with yttrium-86: comparison of phantom measurements acquired with different PET scanners before and after applying background subtraction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1470-9

Quantitative imaging of yttrium-86 PET with the ECAT EXACT HR+ in 2D mode.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1470-9

Early dose response to yttrium-90 microsphere treatment of metastatic liver cancer by a patient-specific method using single photon emission computed tomography and positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1470-9

Recommendations for radioembolization of hepatic malignancies using yttrium-90 microsphere brachytherapy: a consensus panel report from the radioembolization brachytherapy oncology consortium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1470-9

State of the art in nuclear medicine dose assessment

21 January 2018

1 reference

12 December 2020

Combination radionuclide therapy using 177Lu- and 90Y-labeled somatostatin analogs.

1 reference

12 December 2020

Yttrium-90 biodistribution by yttrium-87 imaging: a theoretical feasibility analysis

1 reference

12 December 2020

Yttrium-90 and indium-111 labelling, receptor binding and biodistribution of [DOTA0,d-Phe1,Tyr3]octreotide, a promising somatostatin analogue for radionuclide therapy

1 reference

12 December 2020

Patient-specific dosimetry in predicting renal toxicity with (90)Y-DOTATOC: relevance of kidney volume and dose rate in finding a dose-effect relationship

1 reference

12 December 2020

Quantitative bremsstrahlung imaging of yttrium-90 using a Wiener filter

1 reference

12 December 2020

MIRD pamphlet No. 20: the effect of model assumptions on kidney dosimetry and response--implications for radionuclide therapy.

1 reference

12 December 2020

OLINDA/EXM: the second-generation personal computer software for internal dose assessment in nuclear medicine

1 reference

12 December 2020

Beta voxel S values for internal emitter dosimetry.

1 reference

12 December 2020

Posttherapy radiation safety considerations in radiomicrosphere treatment with 90Y-microspheres

1 reference

12 December 2020

Dosimetry in Peptide radionuclide receptor therapy: a review.

1 reference

12 December 2020

Re-evaluation of absorbed fractions for photons and electrons in spheres of various sizes

1 reference

12 December 2020

Clinical radionuclide therapy dosimetry: the quest for the "Holy Gray".

1 reference

12 December 2020

Preclinical evaluation of intravenously administered 111In- and 90Y-labeled B72.3 immunoconjugate (GYK-DTPA) in beagle dogs

1 reference

12 December 2020

MIRD pamphlet No. 17: the dosimetry of nonuniform activity distributions--radionuclide S values at the voxel level. Medical Internal Radiation Dose Committee

1 reference

12 December 2020

Yttrium 90 Bremsstrahlung SPECT/CT scan demonstrating areas of tracer/tumour uptake.

1 reference

12 December 2020

1 reference

12 December 2020

Performance of Philips Gemini TF PET/CT scanner with special consideration for its time-of-flight imaging capabilities.

1 reference

12 December 2020

Evaluation of quantitative (90)Y SPECT based on experimental phantom studies

1 reference

12 December 2020

Quantitative imaging of bromine-76 and yttrium-86 with PET: a method for the removal of spurious activity introduced by cascade gamma rays

1 reference

12 December 2020

Affinity profiles for human somatostatin receptor subtypes SST1-SST5 of somatostatin radiotracers selected for scintigraphic and radiotherapeutic use

1 reference

12 December 2020

Clinical radionuclide therapy dosimetry: the quest for the "Holy Gray"

1 reference

12 December 2020

Practical dosimetry of peptide receptor radionuclide therapy with (90)Y-labeled somatostatin analogs.

1 reference

12 December 2020

Three-dimensional imaging-based radiobiological dosimetry

1 reference

12 December 2020

Clinical applications of newer radionuclide therapies

1 reference

12 December 2020

Yttrium-90 TOF PET scan demonstrates high-resolution biodistribution after liver SIRT.

1 reference

12 December 2020

A new internal pair production branching ratio of 90Y: the development of a non-destructive assay for 90Y and 90Sr

1 reference

12 December 2020

10.1007/S00259-010-1470-9

Identifiers

DOI

1 reference

13 May 2018

1 reference

13 May 2018